peptide elongation factor 2 has been researched along with Abnormalities, Autosome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almasan, A; Huang, LC; Linke, SP; Paulson, TG; Wahl, GM | 1 |
1 review(s) available for peptide elongation factor 2 and Abnormalities, Autosome
| Article | Year |
|---|---|
Genetic instability as a consequence of inappropriate entry into and progression through S-phase.
Topics: Animals; Antimetabolites; Apoptosis; Cell Transformation, Neoplastic; Chromosome Aberrations; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; G1 Phase; Gene Expression Regulation; Genes, p53; Genes, Retinoblastoma; Genome; Humans; Mutation; Neoplasms; Peptide Elongation Factor 2; Peptide Elongation Factors; Protein Kinase Inhibitors; Protein Kinases; Retinoblastoma Protein; S Phase; Tumor Suppressor Protein p53 | 1995 |